We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Agreement Performance Period Sample Clauses

Agreement Performance PeriodThe performance period of this Agreement (“Agreement Performance Period”) begins on January 1, 2024 (the “Start Date”) and ends at 11:59 PM ET on December 31, 2026, unless the Agreement Performance Period or the Agreement is sooner terminated by either party in accordance with Article XVII, in which case the Agreement Performance Period ends on the Day specified by CMS in writing.
Agreement Performance Period. The first Performance Year of the Agreement began on January 1, 2019 (the “Start Date”) and will end on December 31, 2019. Subsequent Performance Years shall each be 12 months in duration, beginning on January 1. The performance period of this Agreement (“Agreement Performance Period”) began on the Start Date and ends at 11:59 PM ET on December 31, 2026, unless the Agreement Performance Period or the Agreement is sooner terminated by either Party in accordance with Article XIV.
Agreement Performance PeriodThe performance period for this Agreement (“Agreement Performance Period”) is the only period of time during the Agreement Term during which a Clinical Episode may initiate. The Agreement Performance Period begins on January 1, 2020 (the “Start Date”) and ends on the applicable date specified in Article 1.3(a) or Article 1.3(b), unless this Agreement or, if applicable, an Amended and Restated Agreement offered pursuant to Article 1.4(a), is sooner terminated by either Party in accordance with Article 21 or in accordance with the terms of such Amended and Restated Agreement. (a) In the event that CMS offers an Amended and Restated Agreement pursuant to Article 1.4(a): (i) If the Participant does not sign the Amended and Restated Agreement by November 15, 2020, the Agreement Performance Period expires at 11:59 PM EST on December 31, 2020. (ii) If the Participant signs the Amended and Restated Agreement by no later than November 15, 2020 (or other such date as CMS may specify in writing), the Agreement Performance Period will be extended beyond December 31, 2020 until 11:59 PM EST on December 31, 2021 and in accordance with the terms specified in the Amended and Restated Agreement. (b) In the event that CMS does not offer an Amended and Restated Agreement pursuant to Article 1.4(a), then the Agreement Performance Period will expire at 11:59 PM EST on December 31, 2023.
Agreement Performance Period. This Agreement shall commence on the 1st day of March 2019, and shall terminate on the 30th day of April 2022 (Agreement End Date), unless extended or terminated earlier, pursuant to the terms and conditions of this Agreement. All work under this Agreement must end on or before the agreement end date.

Related to Agreement Performance Period

  • Performance Period This Agreement shall be performed during the period which begins Oct 01 2020 and ends Sep 30 2022. All services under this Agreement must be rendered within this performance period, unless directly specified under a written change or extension provisioned under Article 14, which shall be fully executed by both parties to this Agreement.

  • Ongoing Performance Measures The Department intends to use performance-reporting tools in order to measure the performance of Contractor(s). These tools will include the Contractor Performance Survey (Exhibit G), to be completed by Customers on a quarterly basis. Such measures will allow the Department to better track Vendor performance through the term of the Contract(s) and ensure that Contractor(s) consistently provide quality services to the State and its Customers. The Department reserves the right to modify the Contractor Performance Survey document and introduce additional performance-reporting tools as they are developed, including online tools (e.g. tools within MFMP or on the Department's website).

  • Annual Performance Bonus During the Employment Term, the Executive shall be entitled to participate in the STIP, with such opportunities as may be determined by the Chief Executive Officer in his sole discretion (“Target Bonuses”), and as may be increased (but not decreased, except for across-the-board reductions generally applicable to the Company’s senior executives) from time to time, and the Executive shall be entitled to receive full payment of any award under the STIP, determined pursuant to the STIP (a “Bonus Award”).

  • Continuing Performance In the event of a dispute, the Owner and the Developer agree to continue their respective performance hereunder to the extent feasible in light of the dispute, including paying xxxxxxxx, and such continuation of efforts and payment of xxxxxxxx shall not be construed as a waiver of any legal right.

  • Annual Performance Review The Employee’s performance of his duties under this Agreement shall be reviewed by the Board of Directors or a committee of the Board of Directors at least annually and finalized within thirty (30) days of the receipt of the annual audited financial statements. The Board of Directors or a committee of the Board of Directors shall additionally review the base salary, bonus and benefits provided to the Employee under this Agreement and may, in their discretion, adjust the same, as outlined in Addendum B of this Agreement, provided, however, that Employee’s annual base salary shall not be less than the base salary set forth in Section 4(A) hereof.

  • Employee Performance Review When a formal review of an employee’s performance is made, the employee concerned shall be given an opportunity to discuss, sign and make written comments on the review form in question and the employee is to receive a signed copy to indicate that its contents have been read. An employee shall be entitled to a minimum of two (2) work days to review the performance review prior to providing any response to the Employer, verbally or in writing, with respect to the evaluation.

  • Performance Pay In accordance with Section 8 of the General Appropriations Act for Fiscal Year 2020-2021, contingent upon the availability of funds and at the Agency Head’s discretion, each agency is authorized to grant merit pay increases based on the employee’s exemplary performance, as evidenced by a performance evaluation conducted pursuant to Rule 60L-35, Florida Administrative Code.

  • Measurement Period In this Agreement, unless the contrary intention appears, a reference to:

  • Performance Measure Grantee will adhere to the performance measures requirements documented in

  • Financial Performance Covenants Notwithstanding anything to the contrary contained in Section 7.01, in the event that the U.S. Borrower fails to comply with the requirements of any Financial Performance Covenant, until the expiration of the 10th day subsequent to the date the certificate calculating such Financial Performance Covenant is required to be delivered pursuant to Section 5.04(c), Holdings shall have the right to issue Permitted Cure Securities for cash or otherwise receive cash contributions to the capital of Holdings, and, in each case, to contribute any such cash to the capital of Intermediate Holdings (which shall contribute all such cash to the capital of the U.S. Borrower) (collectively, the "Cure Right"), and upon the receipt by U.S. Borrower of such cash (the "Cure Amount") pursuant to the exercise by Holdings of such Cure Right such Financial Performance Covenant shall be recalculated giving effect to the following pro forma adjustments: (i) EBITDA shall be increased, solely for the purpose of measuring the Financial Performance Covenants and not for any other purpose under this Agreement, by an amount equal to the Cure Amount; and (ii) If, after giving effect to the foregoing recalculations, the U.S. Borrower shall then be in compliance with the requirements of all Financial Performance Covenants, the U.S. Borrower shall be deemed to have satisfied the requirements of the Financial Performance Covenants as of the relevant date of determination with the same effect as though there had been no failure to comply therewith at such date, and the applicable breach or default of the Financial Performance Covenants that had occurred shall be deemed cured for this purposes of the Agreement.